Pflug Koory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.42K | Hold |
80
| – | – | ﹤0.01% | 371 |
|
|
2025
Q4 | $3.92K | Hold |
80
| – | – | ﹤0.01% | 373 |
|
|
2025
Q3 | $3.45K | Hold |
80
| – | – | ﹤0.01% | 376 |
|
|
2025
Q2 | $3.07K | Hold |
80
| – | – | ﹤0.01% | 371 |
|
|
2025
Q1 | $3.1K | Hold |
80
| – | – | ﹤0.01% | 358 |
|
|
2024
Q4 | $2.71K | Hold |
80
| – | – | ﹤0.01% | 368 |
|
|
2024
Q3 | $3.27K | Buy |
+80
| New | +$3.27K | ﹤0.01% | 365 |
|
|
2024
Q1 | $6K | Hold |
140
| – | – | ﹤0.01% | 345 |
|
|
2023
Q4 | $5.19K | Hold |
140
| – | – | ﹤0.01% | 358 |
|
|
2023
Q3 | $5.08K | Hold |
140
| – | – | ﹤0.01% | 351 |
|
|
2023
Q2 | $4.99K | Hold |
140
| – | – | ﹤0.01% | 360 |
|
|
2023
Q1 | $4.98K | Sell |
140
-120
| -46% | -$4.2K | ﹤0.01% | 369 |
|
|
2022
Q4 | $9K | Sell |
260
-620
| -70% | -$20.7K | 0.01% | 340 |
|
|
2022
Q3 | $26K | Buy |
+880
| New | +$33.4K | 0.02% | 272 |
|
|
2022
Q2 | – | Sell |
-1,177
| Closed | -$64K | – | 455 |
|
|
2022
Q1 | $64K | Hold |
1,177
| – | – | 0.03% | 234 |
|
|
2021
Q4 | $65K | Hold |
1,177
| – | – | 0.03% | 233 |
|
|
2021
Q3 | $56K | Hold |
1,177
| – | – | 0.03% | 238 |
|
|
2021
Q2 | $59K | Hold |
1,177
| – | – | 0.03% | 240 |
|
|
2021
Q1 | $52K | Buy |
1,177
+272
| +30% | +$12.3K | 0.03% | 238 |
|
|
2020
Q4 | $42K | Buy |
905
+280
| +45% | +$12.9K | 0.02% | 250 |
|
|
2020
Q3 | $29K | Buy |
625
+245
| +64% | +$12.3K | 0.02% | 253 |
|
|
2020
Q2 | $19K | Hold |
380
| – | – | 0.01% | 272 |
|
|
2020
Q1 | $18K | Hold |
380
| – | – | 0.02% | 265 |
|
|
2019
Q4 | $22K | Hold |
380
| – | – | 0.02% | 270 |
|
|
2019
Q3 | $20K | Hold |
380
| – | – | 0.02% | 273 |
|
|
2019
Q2 | $19K | Hold |
380
| – | – | 0.01% | 275 |
|
|
2019
Q1 | $20K | Hold |
380
| – | – | 0.02% | 280 |
|
|
2018
Q4 | $18K | Hold |
380
| – | – | 0.02% | 273 |
|
|
2018
Q3 | $19K | Sell |
380
-40
| -10% | -$2.03K | 0.02% | 285 |
|
|
2018
Q2 | $21K | Hold |
420
| – | – | 0.02% | 277 |
|
|
2018
Q1 | $21K | Sell |
420
-1,160
| -73% | -$54K | 0.02% | 274 |
|
|
2017
Q4 | $70K | Hold |
1,580
| – | – | 0.06% | 192 |
|
|
2017
Q3 | $80K | Buy |
1,580
+120
| +8% | +$6.09K | 0.07% | 181 |
|
|
2017
Q2 | $79K | Hold |
1,460
| – | – | 0.07% | 183 |
|
|
2017
Q1 | $76K | Hold |
1,460
| – | – | 0.07% | 182 |
|
|
2016
Q4 | $70 | Buy |
+1,460
| New | +$72.1K | 0.06% | 183 |
|
Other funds holding GSK
JEST
Pflug Koory's GSK Position: Q1 2026 in Review
Pflug Koory held its GSK (GSK) position steady in Q1 2026 at 80 shares worth $4.42K. The position accounts for ﹤0.01% of the portfolio, ranked #371.
Pflug Koory first reported a position in GSK in Q4 2016 and has held it in 36 quarters since. The position peaked at $80K in Q3 2017. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Pflug Koory held 80 shares of GSK worth $4.42K as of Q1 2026.
- Pflug Koory left its GSK share count unchanged in Q1 2026.
- GSK made up ﹤0.01% of Pflug Koory's portfolio in Q1 2026, its #371 holding.
- Pflug Koory first reported a position in GSK in Q4 2016 and has held it in 36 quarters since.
- Pflug Koory's GSK position peaked at $80K in Q3 2017.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Pflug Koory's 13F filing for Q1 2026, filed 22 Apr 2026.